Literature DB >> 15482957

Mutation screening in Korean hypokalemic periodic paralysis patients: a novel SCN4A Arg672Cys mutation.

Myeong-Kyu Kim1, Seung-Han Lee, Man-Seok Park, Byeong-Chae Kim, Ki-Hyun Cho, Min-Cheol Lee, Jin-Hee Kim, Seung-Min Kim.   

Abstract

Familial hypokalemic periodic paralysis is an autosomal-dominant disorder with features of both genetic and phenotypic heterogeneity. Mutation screening was performed on Korean hypokalemic periodic paralysis patients to locate the corresponding mutations and to specify the clinical features associated with the mutations. Target-exon PCR, direct sequencing, and restriction fragment length polymorphism analysis were used. A novel SCN4A Arg672Cys mutation and a known CACNL1A3 Arg528His mutation were identified. Incomplete penetrance in women with Arg672Cys mutation was evident. A comparison of the present study with previous studies raises the possibility that hypokalemic periodic paralysis is an allelic-specific or mulfactorial, rather than a gene-specific, disorder. Reported herein are two Korean hypokalemic periodic paralysis families, one carrying a novel SCN4A Arg672Cys mutation with incomplete penetrance in women, and the other carrying a CACNL1A3 Arg528His mutation, with the onset of characteristics of hypoPP developing at an earlier age, as well as a higher penetrance rate in women.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15482957     DOI: 10.1016/j.nmd.2004.07.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  8 in total

Review 1.  Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis?

Authors:  E Matthews; M G Hanna
Journal:  J Physiol       Date:  2010-02-01       Impact factor: 5.182

Review 2.  Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder.

Authors:  Bertrand Fontaine; Emmanuel Fournier; Damien Sternberg; Savine Vicart; Nacira Tabti
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

3.  Skeletal muscle na channel disorders.

Authors:  Dina Simkin; Saïd Bendahhou
Journal:  Front Pharmacol       Date:  2011-10-14       Impact factor: 5.810

4.  Hypokalemic periodic paralysis; two different genes responsible for similar clinical manifestations.

Authors:  Hunmin Kim; Hee Hwang; Hae Il Cheong; Hye Won Park
Journal:  Korean J Pediatr       Date:  2011-11-30

5.  Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis.

Authors:  Silvia Corrochano; Roope Männikkö; Peter I Joyce; Philip McGoldrick; Jessica Wettstein; Glenda Lassi; Dipa L Raja Rayan; Gonzalo Blanco; Colin Quinn; Andrianos Liavas; Arimantas Lionikas; Neta Amior; James Dick; Estelle G Healy; Michelle Stewart; Sarah Carter; Marie Hutchinson; Liz Bentley; Pietro Fratta; Andrea Cortese; Roger Cox; Steve D M Brown; Valter Tucci; Henning Wackerhage; Anthony A Amato; Linda Greensmith; Martin Koltzenburg; Michael G Hanna; Abraham Acevedo-Arozena
Journal:  Brain       Date:  2014-10-27       Impact factor: 13.501

6.  Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis.

Authors:  E Matthews; R Labrum; M G Sweeney; R Sud; A Haworth; P F Chinnery; G Meola; S Schorge; D M Kullmann; M B Davis; M G Hanna
Journal:  Neurology       Date:  2008-12-31       Impact factor: 9.910

7.  The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis.

Authors:  June Bum Kim; Man Ho Kim; Soon Ju Lee; Dae Joong Kim; Byung Churl Lee
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

8.  Do motor control genes contribute to interindividual variability in decreased movement in patients with pain?

Authors:  Bikash K Mishra; Tianxia Wu; Inna Belfer; Colin A Hodgkinson; Leonardo G Cohen; Carly Kiselycznyk; Albert Kingman; Robert B Keller; Qiaoping Yuan; David Goldman; Steven J Atlas; Mitchell B Max
Journal:  Mol Pain       Date:  2007-07-26       Impact factor: 3.395

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.